- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Eisai Co Ltd (4523)
| Open: | 4,500 | Day's Range: | 4,170 - 4,515 | Volume: | 2,848,700 |
|---|---|---|---|---|---|
| Previous Close: | 4,430 | 52wk Range: | 3,135 - 4,675 | 1-Yr Rtn: | +37.01% |
Key Statistics for 4523
| Current P/E Ratio (ttm) | 24.6768 |
|---|---|
| Estimated P/E(03/2014) | 22.2881 |
| Relative P/E vs. TPX | 0.9954 |
| Earnings Per Share (JPY) (ttm) | 169.3900 |
| Est. EPS (JPY) (03/2014) | 187.5440 |
| Est. PEG Ratio | - |
| Market Cap (M JPY) | 1,239,649.88 |
| Shares Outstanding (M) | 296.57 |
| 30 Day Average Volume | 1,329,617 |
| Price/Book (mrq) | 2.5331 |
| Price/Sale (ttm) | 2.0767 |
| Dividend Indicated Gross Yield | 3.59% |
| Cash Dividend (JPY) | 70.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 2.90% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4523
Company Profile & Key Executives for 4523
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
| Haruo NaitoPresident/CEO | Lynn KramerPresdent:Neuroscience |
| Hideshi HondaDeputy President | Hajime ShimizuDeputy President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4523 News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page